OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
5.19
+0.09 (1.76%)
May 29, 2026, 4:00 PM EDT - Market closed
OptimizeRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 107.35 | 109.43 | 92.13 | 71.52 | 62.45 | 61.29 | |
Revenue Growth (YoY) | 13.76% | 18.78% | 28.81% | 14.53% | 1.89% | 41.51% |
Cost of Revenue | 32.16 | 35.83 | 32.75 | 28.62 | 23.48 | 25.65 |
Gross Profit | 60.25 | 73.6 | 59.38 | 42.9 | 38.97 | 35.64 |
Selling, General & Admin | 52.91 | 57.21 | 61.27 | 58.02 | 49.24 | 33.19 |
Depreciation & Amortization Expenses | 4.3 | 4.33 | 4.33 | 2.4 | 2.02 | 2.09 |
Research & Development | 3.4 | - | - | - | - | - |
Other Operating Expenses | 0.37 | 0.37 | 7.49 | 8.88 | - | - |
Total Operating Expenses | 60.98 | 61.9 | 73.08 | 69.3 | 51.26 | 35.28 |
Operating Income | 14.2 | 11.69 | -13.71 | -26.4 | -12.29 | 0.36 |
Interest Income | 0.34 | 0.35 | 0.33 | 2.19 | 0.85 | 0.02 |
Interest Expense | -5.15 | -5.29 | -6.16 | -1.45 | - | - |
Other Non-Operating Income (Expense) | 0.13 | 0.2 | 0.15 | 0.5 | - | - |
Total Non-Operating Income (Expense) | -4.68 | -4.74 | -5.68 | 1.24 | 0.85 | 0.02 |
Pretax Income | 9.59 | 6.95 | -19.39 | -25.16 | -11.44 | 0.38 |
Provision for Income Taxes | -3.05 | -1.82 | -0.73 | 7.6 | - | - |
Net Income | 4.53 | 5.13 | -20.11 | -17.57 | -11.44 | 0.38 |
Net Income to Common | 4.53 | 5.13 | -20.11 | -17.57 | -11.44 | 0.38 |
Shares Outstanding (Basic) | 19 | 19 | 18 | 17 | 18 | 17 |
Shares Outstanding (Diluted) | 19 | 19 | 18 | 17 | 18 | 18 |
Shares Change (YoY) | 4.28% | 3.86% | 6.82% | -3.71% | 0.53% | 19.30% |
EPS (Basic) | 0.36 | 0.28 | -1.10 | -1.03 | -0.64 | 0.02 |
EPS (Diluted) | 0.35 | 0.27 | -1.10 | -1.03 | -0.64 | 0.02 |
Shares Outstanding | 18.77 | 18.76 | 18.45 | 18.15 | 17.15 | 17.86 |
Free Cash Flow | 7.24 | 18.66 | 4.78 | -7.33 | 10.57 | 0.63 |
Free Cash Flow Growth | -61.17% | 290.56% | - | - | 1589.76% | - |
Free Cash Flow Per Share | 0.38 | 0.98 | 0.26 | -0.43 | 0.59 | 0.04 |
Gross Margin | 56.13% | 67.25% | 64.45% | 59.98% | 62.40% | 58.14% |
Operating Margin | 13.23% | 10.69% | -14.88% | -36.91% | -19.68% | 0.59% |
Profit Margin | 4.22% | 4.69% | -21.83% | -24.56% | -18.32% | 0.62% |
FCF Margin | 6.75% | 17.05% | 5.19% | -10.24% | 16.93% | 1.02% |
EBITDA | 18.5 | 16.02 | -9.38 | -24 | -10.27 | 2.33 |
EBITDA Margin | 17.24% | 14.64% | -10.18% | -33.56% | -16.44% | 3.80% |
EBIT | 14.2 | 11.69 | -13.71 | -26.4 | -12.29 | 0.36 |
EBIT Margin | 13.23% | 10.69% | -14.88% | -36.91% | -19.68% | 0.59% |
Effective Tax Rate | -31.82% | -26.16% | 3.74% | -30.19% | 0.00% | 0.00% |